Anders Kvanta
St. Erik Eye Hospital · St Eriks Eye Hospital · S:t Erik's Eye Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anders Kvanta as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:17 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT03709745 · Eylea and Lucentis for Macular Edema in Branch Retinal Vein OcclusionSt. Erik Eye Hospital · completed · Branch Retinal Vein Occlusion with Macular Edema · principal investigator
- N/ANCT01478763 · Vitrous Analysis in Proliferative Diabetic RetinopathyAnders Kvanta · completed · Proliferative Diabetic Retinopathy · principal investigator
- Ph2NCT01478737 · Intravitreal Ozurdex After Pars Plana Vitrectomy for Proliferative Diabetic RetinopathyAnders Kvanta · completed · Proliferative Diabetic Retinopathy · principal investigator
- Ph3NCT00906685 · Bevacizumab for Central Retinal Vein Occlusion StudyAnders Kvanta · completed · Central Retinal Vein Occlusion · principal investigator
- Ph3NCT00599222 · The Ranibizumab Plus Transpupillary Thermotherapy for Neovascular Age-Related Macular Degeneration (AMD) StudyAnders Kvanta · completed · Neovascular Age-related Macular Degeneration · principal investigator
- Ph3NCT00390026 · The Avastin vs Visudyne for Neovascular AMD StudySt. Erik Eye Hospital · withdrawn · Age-related Macular Degeneration · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:17 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:17 UTC. The ranking covers the 200 most relevant of 11 PubMed records, and a shared surname and initials can bring in a namesake. All 11 on PubMed
- Benefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study.Ophthalmology · 2012104 citationsRCR 5.0
- Bevacizumab for macular edema in central retinal vein occlusion: a prospective, randomized, double-masked clinical study.Ophthalmology · 201287 citationsRCR 4.1
- Optical Coherence Tomography Angiography in Central Retinal Vein Occlusion: Correlation Between the Foveal Avascular Zone and Visual Acuity.Invest Ophthalmol Vis Sci · 201677 citationsRCR 5.0
- 22 citationsRCR 1.8
- Interim safety and efficacy of gene therapy for RLBP1-associated retinal dystrophy: a phase 1/2 trial.Nat Commun · 202421 citationsRCR 3.4
- Intravitreal bevacizumab in central retinal vein occlusion: 18-month results of a prospective clinical trial.Eur J Ophthalmol · 201120 citationsRCR 1.0
- Combination therapy with low-dose transpupillary thermotherapy and intravitreal ranibizumab for neovascular age-related macular degeneration: a 24-month prospective randomised clinical study.Br J Ophthalmol · 201215 citationsRCR 0.6
- Preoperative sub-Tenon's capsule injection of ropivacaine in conjunction with general anesthesia in retinal detachment surgery.Ophthalmology · 200714 citationsRCR 0.6
- Vitamin D Deficiency in Patients with Central Retinal Vein Occlusion: A Case Control Study.Curr Eye Res · 201714 citationsRCR 0.8
- A prospective randomised study on low-dose transpupillary thermotherapy versus photodynamic therapy for neovascular age-related macular degeneration.Br J Ophthalmol · 20087 citationsRCR 0.3